| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.
|
Bone Marrow Transplant
|
2010
|
3.46
|
|
2
|
Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
|
Blood
|
2001
|
1.93
|
|
3
|
Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis.
|
Eur J Clin Microbiol Infect Dis
|
1996
|
1.89
|
|
4
|
Molecular typing of environmental and patient isolates of Aspergillus fumigatus from various hospital settings.
|
J Clin Microbiol
|
1998
|
1.68
|
|
5
|
Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study.
|
Cancer
|
2001
|
1.59
|
|
6
|
Unusual complications after bone marrow transplantation for dyskeratosis congenita.
|
Br J Haematol
|
1998
|
1.47
|
|
7
|
Management of CMV infections: recommendations from the infectious diseases working party of the EBMT.
|
Bone Marrow Transplant
|
2004
|
1.40
|
|
8
|
Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation.
|
J Clin Oncol
|
2000
|
1.39
|
|
9
|
Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies.
|
Bone Marrow Transplant
|
2007
|
1.28
|
|
10
|
The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation.
|
Leukemia
|
2010
|
1.26
|
|
11
|
Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
|
J Antimicrob Chemother
|
2006
|
1.26
|
|
12
|
Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT.
|
Bone Marrow Transplant
|
2005
|
1.25
|
|
13
|
Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
|
Bone Marrow Transplant
|
2003
|
1.24
|
|
14
|
Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de Moelle.
|
Blood
|
1996
|
1.23
|
|
15
|
Adriamycin cardiotoxicity: a survey of 1273 patients.
|
Cancer Treat Rep
|
1979
|
1.22
|
|
16
|
Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients.
|
Br J Haematol
|
2001
|
1.19
|
|
17
|
Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation.
|
Clin Infect Dis
|
2000
|
1.19
|
|
18
|
Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia.
|
Leukemia
|
2008
|
1.14
|
|
19
|
Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: results of a 5 year retrospective study.
|
Bone Marrow Transplant
|
1993
|
1.08
|
|
20
|
Impact of comorbidity indexes on non-relapse mortality.
|
Leukemia
|
2008
|
1.06
|
|
21
|
A phase I trial of trans-1-diaminocyclohexane oxalato-platinum (l-OHP).
|
Biomed Pharmacother
|
1986
|
1.04
|
|
22
|
Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients.
|
J Hosp Infect
|
2001
|
1.00
|
|
23
|
Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients.
|
Bone Marrow Transplant
|
2004
|
0.99
|
|
24
|
Outcomes, infections, and immune reconstitution after double cord blood transplantation in patients with high-risk hematological diseases.
|
Transpl Infect Dis
|
2011
|
0.99
|
|
25
|
Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis.
|
Bone Marrow Transplant
|
2012
|
0.98
|
|
26
|
Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors.
|
Br J Haematol
|
1994
|
0.98
|
|
27
|
Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes.
|
Bone Marrow Transplant
|
2004
|
0.98
|
|
28
|
MR of cerebral aspergillosis in patients who have had bone marrow transplantation.
|
AJNR Am J Neuroradiol
|
1995
|
0.97
|
|
29
|
A 10-year median follow-up study after allogeneic stem cell transplantation for chronic myeloid leukemia in chronic phase from HLA-identical sibling donors.
|
Leukemia
|
2005
|
0.97
|
|
30
|
Therapeutic outcome and prognostic factors of invasive aspergillosis in an infectious disease department: a review of 34 cases.
|
Infection
|
2008
|
0.97
|
|
31
|
Evaluation of a new 5'-nuclease real-time PCR assay targeting the Toxoplasma gondii AF146527 genomic repeat.
|
Clin Microbiol Infect
|
2009
|
0.95
|
|
32
|
Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipients.
|
Bone Marrow Transplant
|
2005
|
0.94
|
|
33
|
Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study.
|
Bone Marrow Transplant
|
2005
|
0.92
|
|
34
|
Treatment of T-prolymphocytic leukemia with nonmyeloablative allogeneic stem cell transplantation.
|
Eur J Haematol
|
2001
|
0.92
|
|
35
|
Short- and long-term follow-up of thyroid dysfunction after allogeneic bone marrow transplantation without the use of preparative total body irradiation.
|
Br J Haematol
|
1997
|
0.92
|
|
36
|
Bone marrow transplantation for paroxysmal nocturnal haemoglobinuria.
|
Br J Haematol
|
1999
|
0.91
|
|
37
|
Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation.
|
Bone Marrow Transplant
|
2007
|
0.91
|
|
38
|
Transplantation for Fanconi's anaemia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning.
|
Br J Haematol
|
1998
|
0.90
|
|
39
|
Fungal infection prevention after hematopoietic cell transplantation.
|
Bone Marrow Transplant
|
2009
|
0.90
|
|
40
|
High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia.
|
Clin Microbiol Infect
|
2009
|
0.89
|
|
41
|
Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT.
|
Bone Marrow Transplant
|
1993
|
0.88
|
|
42
|
Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation.
|
Br J Haematol
|
2001
|
0.88
|
|
43
|
Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3 days of G-CSF identifies long-term responders.
|
Bone Marrow Transplant
|
2005
|
0.87
|
|
44
|
Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients.
|
Bone Marrow Transplant
|
1994
|
0.87
|
|
45
|
Toxoplasmic pneumonitis leading to fatal acute respiratory distress syndrome after engraftment in three bone marrow transplant recipients.
|
Transplantation
|
2001
|
0.87
|
|
46
|
Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia.
|
Bone Marrow Transplant
|
2001
|
0.86
|
|
47
|
DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation.
|
Bone Marrow Transplant
|
2002
|
0.85
|
|
48
|
Hepatosplenic candidiasis in the era of new antifungal drugs: a study in Paris 2000-2007.
|
Clin Microbiol Infect
|
2012
|
0.84
|
|
49
|
Double cord blood transplantation in patients with high risk bone marrow failure syndromes.
|
Br J Haematol
|
2008
|
0.84
|
|
50
|
Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group--Infectious Diseases Working Party.
|
Bone Marrow Transplant
|
1994
|
0.84
|
|
51
|
Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization.
|
Bone Marrow Transplant
|
2000
|
0.84
|
|
52
|
Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008).
|
Clin Microbiol Infect
|
2012
|
0.84
|
|
53
|
Tibial artery thrombosis due to varicella zoster virus in a transplant recipient under cyclosporine.
|
Eur J Med
|
1993
|
0.83
|
|
54
|
Changing patterns of infections and antimicrobial susceptibilities.
|
Oncology (Williston Park)
|
2000
|
0.83
|
|
55
|
Significance of herpesvirus 6 in BAL fluid of hematology patients with acute respiratory failure.
|
Infection
|
2011
|
0.82
|
|
56
|
Study of nitrosourea glycosyl analogs--V. An oriented phase II trial of RFCNU.
|
Eur J Cancer Clin Oncol
|
1982
|
0.81
|
|
57
|
Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine.
|
Cancer Treat Rep
|
1978
|
0.81
|
|
58
|
Monitoring of nosocomial invasive aspergillosis and early evidence of an outbreak using cumulative sum tests (CUSUM).
|
Clin Microbiol Infect
|
2010
|
0.81
|
|
59
|
Outbreak in a haematology unit involving an unusual strain of glycopeptide-resistant Enterococcus faecium carrying both vanA and vanB genes.
|
J Antimicrob Chemother
|
2013
|
0.80
|
|
60
|
Hypersensitivity pneumonitis related to imatinib mesylate.
|
J Clin Oncol
|
2002
|
0.79
|
|
61
|
Correlation between precancerous bronchial metaplasia and cigarette consumption, and preliminary results of retinoid treatment.
|
Cancer Detect Prev
|
1982
|
0.79
|
|
62
|
Phase I trials in clinical oncostatic pharmacology.
|
Cancer Chemother Pharmacol
|
1980
|
0.79
|
|
63
|
Vindesine: a new vinca alkaloid.
|
Recent Results Cancer Res
|
1980
|
0.79
|
|
64
|
Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients.
|
Transplantation
|
2000
|
0.78
|
|
65
|
Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality.
|
Bone Marrow Transplant
|
2003
|
0.78
|
|
66
|
Phase I-II study of aclarubicin for treatment of acute myeloid leukemia.
|
Cancer Treat Rep
|
1984
|
0.78
|
|
67
|
Cost effectiveness of posaconazole in the prophylaxis of invasive fungal infections in acute leukaemia patients for the French healthcare system.
|
J Med Econ
|
2010
|
0.78
|
|
68
|
The epidemiology of invasive Streptococcus pneumoniae infections in onco-haematology and haematopoietic stem cell transplant patients in France. Are the serotypes covered by the available anti-pneumococcal vaccines?
|
Clin Microbiol Infect
|
2009
|
0.78
|
|
69
|
Kinetics and metabolism of a new fluoropyrimidine, 5'-deoxy-5-fluorouridine, in humans.
|
Cancer Res
|
1983
|
0.77
|
|
70
|
New oral formulation of cyclosporin A (Neoral) pharmacokinetics in allogeneic bone marrow transplant recipients.
|
Bone Marrow Transplant
|
2000
|
0.76
|
|
71
|
Hematon, a multicellular functional unit in normal human bone marrow: structural organization, hemopoietic activity, and its relationship to myelodysplasia and myeloid leukemias.
|
Exp Hematol
|
1990
|
0.76
|
|
72
|
Relationship between HLA alleles and cytomegalovirus infection after allogenic hematopoietic stem cell transplant.
|
Blood
|
2001
|
0.76
|
|
73
|
Hodgkin's disease of donor origin after allogeneic bone marrow transplantation for myelogeneous chronic leukemia.
|
Transplantation
|
1998
|
0.76
|
|
74
|
Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplants.
|
Exp Hematol
|
2001
|
0.76
|
|
75
|
Experimental ultrastructural and X-ray microanalysis study of cisplatin in the rat: intracellular localization of platinum.
|
Cancer Treat Rep
|
1982
|
0.76
|
|
76
|
Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. An oncostatic anthracyclin that is rarely cardiotoxic and induces no alopecia.
|
Cancer Chemother Pharmacol
|
1978
|
0.76
|
|
77
|
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
|
Bone Marrow Transplant
|
1995
|
0.75
|
|
78
|
Treatment of lymphoid neoplasias with interferon. II. Human leucocyte alpha-interferon in chronic lymphatic leukemia (CLL). PHase I-II trial.
|
Anticancer Res
|
1982
|
0.75
|
|
79
|
MR and chemotherapy.
|
Neurology
|
1996
|
0.75
|
|
80
|
Different aetiologies of reversible MRI abnormalities in transplant recipients.
|
Neuroradiology
|
1996
|
0.75
|
|
81
|
Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation.
|
Eur Respir J
|
2011
|
0.75
|
|
82
|
[Treatment of leukemias and lymphomas by interferons: II. Phase II of the trial treatment of chronic lymphoid leukemia by human interferon alpha+].
|
Biomed Pharmacother
|
1982
|
0.75
|
|
83
|
[Trial of androgen therapy in the treatment of non-lymphoblastic acute leukemia. First results].
|
Nouv Presse Med
|
1976
|
0.75
|
|
84
|
Phase II trial of aclacinomycin in acute leukemia and lymphosarcoma.
|
Recent Results Cancer Res
|
1980
|
0.75
|
|
85
|
[Treatment of PT1 tumors of the bladder using transurethral resection and intravesical immunotherapy].
|
Ann Urol (Paris)
|
1990
|
0.75
|
|
86
|
Treatment of acute myeloid leukemia with a combination of intensive induction chemotherapy, early consolidation, splenectomy and long-term maintenance chemotherapy.
|
Cancer
|
1984
|
0.75
|
|
87
|
Clinical pharmacology and pharmacokinetics of cis-platinum and analogs.
|
Cancer Treat Rep
|
1981
|
0.75
|
|
88
|
[Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)].
|
Nouv Presse Med
|
1978
|
0.75
|
|
89
|
Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic beta-interferon in malignant gammapathies. Phase II trial.
|
Anticancer Res
|
1982
|
0.75
|
|
90
|
Indications and timing of allogeneic bone marrow transplantation in myelodysplastic syndromes.
|
Leuk Lymphoma
|
1997
|
0.75
|
|
91
|
An oriented phase II trial of THP-adriamycin in breast carcinoma.
|
Biomed Pharmacother
|
1986
|
0.75
|
|
92
|
[Results of 3 protocols of treatment of acute lymphoid leukemia in children].
|
Arch Fr Pediatr
|
1978
|
0.75
|
|
93
|
[Hemangioendotheliosarcoma of the erectile bodies. Apropos of a case].
|
Ann Urol (Paris)
|
1987
|
0.75
|
|
94
|
Combined differentiation therapy in myelodysplastic syndrome with retinoid acid, 1 alpha,25 dihydroxyvitamin D3, and prednisone.
|
Cancer Detect Prev
|
1992
|
0.75
|
|
95
|
Severe oesophagitis after allogeneic bone marrow transplantation for Fanconi's anemia.
|
Bone Marrow Transplant
|
2000
|
0.75
|
|
96
|
[Protocols for the treatment of leukemia and lymphoma: toward escalation or toward reduction of degree?].
|
Biomed Pharmacother
|
1984
|
0.75
|
|
97
|
Preliminary results of chemo-radiotherapy followed or not by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma. Correlation of the results with WHO categorisation.
|
Cancer Chemother Pharmacol
|
1978
|
0.75
|
|
98
|
Phase I study of cis-dichloro-trans-dihydroxy-bis(isopropylamine)platinum IV (CHIP).
|
Oncology
|
1986
|
0.75
|
|
99
|
Phase I-II study of aclacinomycin for a treatment of acute myeloid leukemia.
|
Biomed Pharmacother
|
1984
|
0.75
|
|
100
|
Preliminary results of phase I and II clinical trials of RFCNU, a new nitrosourea sugar derivative, in digestive tract tumours.
|
Biomedicine
|
1977
|
0.75
|
|
101
|
Cisplatinumdiamminodichloride (CPDD) in chemotherapy of cancers: a phase II therapeutic trial.
|
Recent Results Cancer Res
|
1980
|
0.75
|
|
102
|
Malignant diseases after allogeneic bone marrow transplantation: an updated overview.
|
Nouv Rev Fr Hematol
|
1994
|
0.75
|
|
103
|
In vitro sensitivity of myeloblast clonogenic cells to doxorubicin, aclacinomycin A, and 4'-O-tetrapyranyl-doxorubicin: correlations with clinical responses.
|
J Clin Oncol
|
1984
|
0.75
|
|
104
|
[Veno-occlusive disease after bone marrow transplantation: preventive effect of heparin].
|
Ann Med Interne (Paris)
|
1997
|
0.75
|
|
105
|
An intensive care chemo- or chemoimmunotherapy regimen for patients with intermediate and poor-prognosis acute lymphatic leukemia and leukemic lymphoblastic lymphosarcoma: preliminary results with 14-month median follow-up.
|
Recent Results Cancer Res
|
1982
|
0.75
|
|
106
|
Preliminary results of three protocols for the treatment of acute lymphoid leukaemia of children: distinction of two groups of patients according to predictable prognosis.
|
Med Pediatr Oncol
|
1978
|
0.75
|
|
107
|
[Treatment of acute myeloid leukemia with a protocol combining intensive induction chemotherapy, early consolidation treatment, splenectomy and long-term maintenance chemotherapy. Preliminary study].
|
Nouv Presse Med
|
1982
|
0.75
|
|
108
|
Preliminary results of chemoradiotherapy followed (or not ) by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma: correlation of the results with WHO categorization.
|
Recent Results Cancer Res
|
1978
|
0.75
|
|
109
|
Doxorubicin, vincristine, bleomycin, cytembena and cisplatin as combination chemotherapy for squamous cell lung cancer.
|
Anticancer Res
|
1983
|
0.75
|
|
110
|
Aclacinomycin A in acute leukaemias and lymphomas.
|
Lancet
|
1979
|
0.75
|
|
111
|
[Treatment of leukemias and lymphomas with interferons: III. Trial treatment of meningeal localizations of acute leukemia and non-Hodgkin's lymphomas with beta interferon administered by the intrathecal route].
|
Biomed Pharmacother
|
1982
|
0.75
|
|
112
|
Pharmacokinetics of Malonato (1,2 diaminocyclohexane) platinum.
|
Cancer Clin Trials
|
1981
|
0.75
|
|
113
|
Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas.
|
Cancer Chemother Pharmacol
|
1979
|
0.75
|
|
114
|
Preclinical and phase I studies of malonatoplatinum.
|
Recent Results Cancer Res
|
1980
|
0.75
|
|
115
|
Chemotherapy of bronchogenic carcinomas by a combination of cyclophosphamide, methotrexate, vincristin and bleomycin.
|
Eur J Cancer
|
1977
|
0.75
|
|
116
|
Progress in the prevention of cytomegalovirus infection after allogeneic bone marrow transplantation.
|
Nouv Rev Fr Hematol
|
1994
|
0.75
|
|
117
|
Influence of various conditioning regimens on the outcome of bone marrow transplantation for leukemia.
|
Nouv Rev Fr Hematol
|
1991
|
0.75
|
|
118
|
Is it justified to neglect the role of chemotherapy in the treatment of prostatic cancer?
|
Prog Clin Biol Res
|
1987
|
0.75
|
|
119
|
Some new chemotherapeutic agents and combinations possibly available for new adjuvant therapies of minimal disease.
|
Recent Results Cancer Res
|
1978
|
0.75
|
|
120
|
[Bone marrow transplantation in the treatment of autoimmune diseases. ISAMAIR Group].
|
Presse Med
|
1999
|
0.75
|
|
121
|
[Aclacinomycin-A in acute leukaemias and leukaemic non-Hodgkin lymphomas (author's transl)].
|
Nouv Presse Med
|
1982
|
0.75
|
|
122
|
Influence of CD34 cell selection on the incidence of mixed chimaerism and minimal residual disease after allogeneic unrelated donor transplantation.
|
Leukemia
|
1998
|
0.75
|
|
123
|
Splenectomy and karyotypic conversion in chronic myeloid leukaemia.
|
Lancet
|
1979
|
0.75
|
|
124
|
[Treatment of leukemias and lymphomas with interferons: I. Trial of myeloma therapy with human beta-interferon].
|
Biomed Pharmacother
|
1982
|
0.75
|